ACPU
ENZY

Arrowgrass Capital Partners (US)’s Enzymotec Ltd ENZY Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-167,125
Closed -$3.68M – 277
2014
Q1 		$3.68M Buy
+167,125
New +$4.43M 0.15% 110

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MCM
Matterhorn Capital Management San Antonio, Texas $151M AUM 14.71% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
MACM
March Altus Capital Management Greenwich, Connecticut $16M AUM 18.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s ENZY Position: Q2 2014 in Review

Arrowgrass Capital Partners (US) sold out of Enzymotec Ltd (ENZY) in Q2 2014, closing a stake of 167,125 shares — an estimated $3.68M sold.

Arrowgrass Capital Partners (US) first reported a position in ENZY in Q1 2014 and held it in 1 quarter. The position peaked at $3.68M in Q1 2014. 25 funds tracked by Wall St. Rank hold ENZY as of Q2 2014.

  • Arrowgrass Capital Partners (US) reported no remaining Enzymotec Ltd position as of Q2 2014 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 167,125 Enzymotec Ltd shares in Q2 2014, an estimated $3.68M.
  • Arrowgrass Capital Partners (US) first reported a position in Enzymotec Ltd in Q1 2014 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Enzymotec Ltd position peaked at $3.68M in Q1 2014.
  • 25 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2014.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2014, filed 14 Aug 2014.